RESTRUCTURING, INTEGRATION AND OTHER COSTS (Details 2) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended								3 Months Ended				12 Months Ended	3 Months Ended			12 Months Ended	3 Months Ended						12 Months Ended		3 Months Ended			12 Months Ended	3 Months Ended			12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 B&L	Sep. 30, 2013 B&L Employee Termination Costs - Severance and Related Benefits	Sep. 30, 2013 B&L Employee Termination Costs - Share-Based Compensation		Sep. 30, 2013 B&L IPR&D Termination Costs	Sep. 30, 2013 B&L Contract Termination, Facility Closure and Other Costs	Sep. 30, 2013 Medicis	Jun. 30, 2013 Medicis	Mar. 31, 2013 Medicis	Dec. 31, 2012 Medicis	Dec. 31, 2012 Medicis	Sep. 30, 2013 Medicis Employee Termination Costs - Severance and Related Benefits	Jun. 30, 2013 Medicis Employee Termination Costs - Severance and Related Benefits	Mar. 31, 2013 Medicis Employee Termination Costs - Severance and Related Benefits	Dec. 31, 2012 Medicis Employee Termination Costs - Severance and Related Benefits	Sep. 30, 2013 Medicis Employee Termination Costs - Share-Based Compensation		Jun. 30, 2013 Medicis Employee Termination Costs - Share-Based Compensation		Mar. 31, 2013 Medicis Employee Termination Costs - Share-Based Compensation		Dec. 31, 2012 Medicis Employee Termination Costs - Share-Based Compensation		Sep. 30, 2013 Medicis IPR&D Termination Costs	Jun. 30, 2013 Medicis IPR&D Termination Costs	Mar. 31, 2013 Medicis IPR&D Termination Costs	Dec. 31, 2012 Medicis IPR&D Termination Costs	Sep. 30, 2013 Medicis Contract Termination, Facility Closure and Other Costs	Jun. 30, 2013 Medicis Contract Termination, Facility Closure and Other Costs	Mar. 31, 2013 Medicis Contract Termination, Facility Closure and Other Costs	Dec. 31, 2012 Medicis Contract Termination, Facility Closure and Other Costs
Restructuring Reserve [Roll Forward]
Balance at the beginning of the period					$ 0	$ 0	$ 0	[1]	$ 0	$ 0	$ 1,194	$ 2,969	$ 11,554		$ 0	$ 1,111	$ 2,831	$ 11,351	$ 0	$ 0	[2]	$ 0	[2]	$ 0	[2]	$ 0	[2]	$ 0	$ 0	$ 0	$ 0	$ 83	$ 138	$ 203	$ 0
Costs incurred and/or charged to expense	(295,890)	(42,872)	(398,540)	(135,213)	217,310	160,486	52,798	[1]	0	4,026	2,065	5,285	15,772	(77,300)	162,952	1,559	5,174	12,902	85,253	0	[2]	0	[2]	0	[2]	77,329	[2]	0	0	0	0	506	111	2,870	370
Cash payments					(81,543)	(27,174)	(52,798)	[1]	0	(1,571)	(2,449)	(7,573)	(24,331)		(155,309)	(1,860)	(7,407)	(21,573)	(77,975)	0	[2]	0	[2]	0	[2]	(77,329)	[2]	0	0	0	0	(589)	(166)	(2,758)	(5)
Non-cash adjustments					(10,181)	(8,284)	0	[1]	0	(1,897)	(389)	513	(26)		3,911	(389)	513	151	4,073	0	[2]	0	[2]	0	[2]	0	[2]	0	0	0	0	0	0	(177)	(162)
Balance at the end of the period					$ 145,948	$ 141,596	$ 0	[1]	$ 0	$ 4,352	$ 421	$ 1,194	$ 2,969	$ 11,554	$ 11,554	$ 421	$ 1,111	$ 2,831	$ 11,351	$ 0	[2]	$ 0	[2]	$ 0	[2]	$ 0	[2]	$ 0	$ 0	$ 0	$ 0	$ 0	$ 83	$ 138	$ 203

[1] Relates to B&L’s previously cancelled performance-based options and the acceleration of unvested stock options for B&L employees as a result of the B&L Acquisition.

[2] Relates to the acceleration of unvested stock options, restricted stock awards, and share appreciation rights for Medicis employees that was triggered by the change in control.